GE Healthcare
100 Results Way
Marlborough
Massachusetts
01752
United States
Tel: 1-800-526-3593
Fax: 1-877-295 -8102
Website: http://www.gehealthcare.com/
Email: cs-us@ge.com
About GE Healthcare
GE Healthcare Life Sciences
The Life Sciences business of GE Healthcare exists to enable and accelerate molecular and precision medicine. We do this by helping our customers discover, make and use new medicines.
Healthcare needs more precise diagnoses and treatments to improve patient outcomes, address the globally rising incidence of lifestyle and chronic diseases, and help reduce the $350 billion wasted each year on poorly-targeted medicines.
We empower researchers with the innovative tools and analytics to research and develop tomorrow’s therapeutics.
We drive productivity for the biopharmaceutical industry and help create manufacturing capacity in under-served markets.
We enable increasingly accurate diagnoses by providing advanced in vivo imaging agents & in vitro diagnostics.
We are helping create the future of regenerative medicine and cell therapy with customers by providing novel tools, technologies and methods.
We work on the things that matter to become trusted partners with our customers, combining our deep expertise, integrity, and heritage in diagnostics and biotechnology with an extensive global network and strength in infrastructure and services.
We are a $4.0 billion business of GE Healthcare serving researchers, pharmaceutical companies, and clinicians.
The Story: GE Healthcare Life Sciences
433 articles about GE Healthcare
-
GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging
4/18/2024
GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence, advanced tools and an ergonomic design to speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health.
-
GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024
4/9/2024
GE HealthCare, a leader in precision care innovation, will announce its first quarter 2024 financial results before the market opens on Tuesday, April 30, 2024.
-
GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist
3/27/2024
GE HealthCare announced the launch of Prostate Volume Assist urology-based artificial intelligence software feature.
-
GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health
3/25/2024
GE HealthCare (Nasdaq: GEHC) announces the U.S. FDA 510(k) Clearance of IONIC Health’s nCommand Lite technology.
-
GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024
3/22/2024
GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology Annual Scientific Meeting taking place March 23-28 in Salt Lake City, UT.
-
Serving Patients and Communities Through Comprehensive Care Solutions: OSF HealthCare, Pointcore, Inc. and GE HealthCare Enter Strategic Care Alliance
2/19/2024
GE HealthCare announced a collaboration with OSF HealthCare, an integrated health system caring for patients throughout Illinois and Michigan, and Pointcore, Inc., a healthcare management and non-clinical shared services company, to help increase clinical and operational efficiencies, standardize care delivery models and improve patient outcomes across OSF HealthCare.
-
GE HealthCare Management to Present at Upcoming Investor Conferences - February 14, 2024
2/14/2024
GE HealthCare, is announcing that its Vice President and Chief Financial Officer, Jay Saccaro, will be presenting at the following upcoming investor conferences.
-
GE HealthCare and MedQuest Associates Collaborate to Provide Innovative Medical Device Technology and Digital Tools for Outpatient Imaging Centers
2/8/2024
GE HealthCare and MedQuest Associates announced a three-year collaboration to deliver excellence in patient care by providing access to innovative technologies from GE HealthCare and the infrastructure and resources from MedQuest that are needed to optimize multi-site outpatient imaging networks for success.
-
GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results
2/6/2024
GE HealthCare, a leading global precision care innovator, reported financial results for the fourth quarter ended December 31, 2023.
-
GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024
1/18/2024
GE HealthCare, a leader in precision care innovation, will announce its fourth quarter and full year 2023 financial results before the market opens on Tuesday, February 6, 2024.
-
GE HealthCare announces agreement to acquire MIM Software
1/8/2024
GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide.
-
GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023
11/29/2023
Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the forefront of leveraging deep learning, a subset of artificial intelligence, to benefit a multitude of clinicians and patients.
-
GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection
11/27/2023
GE HealthCare announced the release of a new, all-in-one platform of artificial intelligence apps to support clinicians with breast cancer detection and improved workflow productivity called MyBreastAI Suite*.
-
GE HealthCare Showcases More Than 40 Innovations, Including AI-Enabled Imaging Technology Solutions Designed for Precision Care at RSNA23
11/26/2023
GE HealthCare will highlight more than 40 innovations, including several key artificial intelligence -enabled technologies within the Imaging, Ultrasound, and digital space at the Radiological Society of North America’s 2023 Annual Meeting taking place Nov. 26-30 in Chicago, IL.
-
GE HealthCare Announces New Version of Digital Expert Access, the First FDA 510(k)-Cleared Device to Enable Remote Patient Scanning, and Exclusive Distribution Agreement with IONIC Health
11/21/2023
GE HealthCare has received U.S. FDA 510 Clearance for the new version of Digital Expert Access with remote scanning, the first remote patient scan solution with 510 Clearance.
-
GE HealthCare to Hold Fireside Chat with Citi Medtech Analyst at RSNA 2023
11/14/2023
GE HealthCare (Nasdaq: GEHC), is announcing today that President and Chief Executive Officer, Peter Arduini, and Vice President and Chief Financial Officer, Jay Saccaro, will hold a fireside chat from the RSNA 2023 annual meeting on Wednesday, November 29 th at 9:15 am ET/8:15 am CT.
-
GE HealthCare Reports Third Quarter 2023 Financial Results
10/31/2023
GE HealthCare, a leading global precision care innovator, reported financial results for the third quarter ended September 30, 2023.
-
GE HealthCare and reLink Medical Collaborate to Help Reduce Medical Device Waste for Healthcare Providers
10/26/2023
GE HealthCare and reLink Medical announced a collaboration to deliver asset management solutions to healthcare providers to help reduce medical device waste, increase operational efficiency and maximize their equipment utilization.
-
GE HealthCare Tops List with Highest Number of AI-Enabled Medical Device Authorizations, Developing Innovative Solutions for Precision Care
10/24/2023
GE HealthCare has topped a U.S. Food and Drug Administration list of artificial intelligence enabled medical devices with 58 listed 510 clearances or authorizations to date in the United States.
-
GE HealthCare to Announce Third Quarter 2023 Results on October 31, 2023
10/17/2023
GE HealthCare, a leader in precision care innovation, will announce its third quarter 2023 financial results before the market opens on Tuesday, October 31, 2023.